Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07488663 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MODELING OBSESSIVE COMPULSIVE DISORDER AND EXPLORING TREATMENT RESPONSE USING INNOVATIVE THERAPIES AND STEM CELLS

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study focuses on people with obsessive-compulsive disorder (OCD) who do not respond well to standard treatments. Researchers aim to understand why some patients respond to medications or brain stimulation therapies, while others do not. The study will include 60 patients grouped by their treatment response: 1. Those who respond to medications 2. Those who respond to transcranial magnetic stimulation (TMS) 3. Those who do not respond to either Blood samples will be used to create nerve cells in the lab, allowing scientists to study how these cells react to treatments and brain stimulation. By combining clinical information with lab findings, the goal is to discover biological markers that predict which therapy will work best for each person. This research hopes to improve personalized treatment options for OCD.
Trial Details
NCT Number NCT07488663
Lead Sponsor ASST Fatebenefratelli Sacco
Collaborators: Fondazione IRCCS San Gerardo dei Tintori, Istittuo ricerca carattere Sceintifico Fatenefratelli Brescia
Conditions
(from sponsor)		 Obsessive - Compulsive Disorder
Related terms Compulsive Personality Disorder, Obsessive-Compulsive Disorder
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov